Literature DB >> 16647436

Living kidney donation: anemia and inflammation in the early postoperative period.

D J Hampel1, J Pratschke, G May, P Reinke, R Schindler.   

Abstract

Studies on living donor kidney transplantation primarily address the recipients; few publications focus on kidney donors. The aim of the present study was to detect changes in and compensations of defined parameters of anemia and inflammation in the immediate postnephrectomy period. We included six living kidney donors who underwent an open anterior-extraperitoneal nephrectomy. We excluded donors with complications, such as significant blood loss or infection. Blood samples were taken before nephrectomy as well as on postoperative days 1, 3, 5, and 7, and at discharge for measurements of hemoglobin (Hb), serum erythropoietin (Epo), reticulocytes (Reti), pentraxin 3 (PTX3), and C-reactive protein (CRP). There was a significant decrease in Hb (>3 g/dL), reaching a maximum on day 3 followed by a significant threefold increase in Epo levels on day 5 and a nonsignificant elevation of Reti count. CRP increased approximately 80-fold on day 3. PTX3 showed a similar course, peaking on day 3 with an approximate 70-fold increase. After living donor nephrectomy, there was an unexpectedly pronounced inflammatory reaction in the absence of any signs of bacterial infection simultaneous with a significant decrease in Hb. These parameters improved during the hospital stay, in some cases they achieved the prenephrectomy level at discharge. These data may assist in interpreting laboratory results after nephrectomy among living kidney donors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16647436     DOI: 10.1016/j.transproceed.2006.01.066

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

1.  Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile.

Authors:  Michela Zanetti; Alessandra Bosutti; Clara Ferreira; Pierandrea Vinci; Gianni Biolo; Maurizio Fonda; Matteo Valente; Luigi Cattin; Gianfranco Guarnieri; Rocco Barazzoni
Journal:  Clin Exp Med       Date:  2009-02-24       Impact factor: 3.984

2.  Anti-Inflammatory Effect of Atorvastatin on the Kidney Graft of Living Donor Transplants.

Authors:  Clotilde Fuentes-Orozco; Sara Jazmín Garcia-Salazar; Benjamín Gómez-Navarro; Eduardo González-Espinoza; Alonso Zepeda-González; Juan Narciso Ramírez-Robles; Rafael Castañeda-Espinoza; Irinea Yáñez-Sánchez; Francisco Javier Gálvez-Gastelum; Gabino Cervantes-Guevara; Guillermo Alonso Cervantes-Cardona; Guadalupe Ivette Contreras-Hernández; Jacob Esau Pérez-Landeros; David García-Martinez; Alejandro González-Ojeda
Journal:  Ann Transplant       Date:  2018-06-29       Impact factor: 1.530

3.  Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors at 5 Years.

Authors:  Anna M Price; William E Moody; Victoria M Stoll; Ravi Vijapurapu; Manvir K Hayer; Luca Biasiolli; Chris J Weston; Rachel Webster; Roman Wesolowski; Kirsty C McGee; Boyang Liu; Shanat Baig; Luke C Pickup; Ashwin Radhakrishnan; Jonathan P Law; Nicola C Edwards; Richard P Steeds; Charles J Ferro; Jonathan N Townend
Journal:  Hypertension       Date:  2021-02-08       Impact factor: 10.190

Review 4.  Risk for subsequent hypertension and cardiovascular disease after living kidney donation: is it clinically relevant?

Authors:  Charles J Ferro; Jonathan N Townend
Journal:  Clin Kidney J       Date:  2021-12-13

5.  Astaxanthin vs placebo on arterial stiffness, oxidative stress and inflammation in renal transplant patients (Xanthin): a randomised controlled trial.

Authors:  Robert G Fassett; Helen Healy; Ritza Driver; Iain K Robertson; Dominic P Geraghty; James E Sharman; Jeff S Coombes
Journal:  BMC Nephrol       Date:  2008-12-18       Impact factor: 2.388

6.  Coronary flow velocity reserve and inflammatory markers in living kidney donors.

Authors:  Ashwin Radhakrishnan; Anna M Price; Luke C Pickup; Jonathan P Law; Kirsty C McGee; Larissa Fabritz; Roxy Senior; Richard P Steeds; Charles J Ferro; Jonathan N Townend
Journal:  Int J Cardiol       Date:  2020-08-14       Impact factor: 4.164

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.